Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
Combining Sorafenib with standard cytotoxic fluoropyrimidine therapy for advanced colorectal
cancer may provide clinical benefit when no other treatment remains.